Cargando…

Motivating deprescribing conversations for patients with Alzheimer’s disease and related dementias: a descriptive study

INTRODUCTION: Older adults with Alzheimer’s disease and related dementias (ADRD) are at increased risk of harm due to prescribing of potentially inappropriate medications. Encouraging patients and caregivers to talk with their providers about potentially inappropriate medications could stimulate dep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antonelli, Mary T., Cox, John S., Saphirak, Cassandra, Gurwitz, Jerry H., Singh, Sonal, Mazor, Kathleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425903/ https://www.ncbi.nlm.nih.gov/pubmed/36052398 http://dx.doi.org/10.1177/20420986221118143

Ejemplares similares

Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials
por: Bloomstone, Sarah, et al.
Publicado: (2020)

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
por: Herrmann, Nathan, et al.
Publicado: (2022)

Deprescribing of Inappropriate Medications for Persons with Dementia in Long-Term Care
por: Sun, Winnie
Publicado: (2021)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Use of Electronic Health Record Access and Audit Logs to Identify Physician Actions Following Noninterruptive Alert Opening: Descriptive Study
por: Amroze, Azraa, et al.
Publicado: (2019)

Interrupting the trajectory of frailty in dementia with Lewy bodies with anabolic exercise, dietary intervention and deprescribing of hazardous medications
por: Inskip, Michael, et al.
Publicado: (2020)

Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia
por: Norton, Jonathan D., et al.
Publicado: (2023)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

A TRIAL TO IMPROVE MEDICATION SAFETY IN OLDER ADULTS: RECRUITMENT CHALLENGES HAVE GENERALIZABILITY IMPLICATIONS
por: Anzuoni, Kathryn, et al.
Publicado: (2019)

Exploration of home care nurse’s experiences in deprescribing of medications: a qualitative descriptive study
por: Sun, Winnie, et al.
Publicado: (2019)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed
por: Reeve, Emily, et al.
Publicado: (2023)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Deprescribing in Frail Older People: A Randomised Controlled Trial
por: Potter, Kathleen, et al.
Publicado: (2016)

The Feasibility of Using N-Of-1 Trials to Investigate Deprescribing in Older Adults with Dementia: A Pilot Study
por: Clough, Alexander J., et al.
Publicado: (2019)

Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)–A hybrid effectiveness-implementation pilot study
por: Benthien, Kirstine Skov, et al.
Publicado: (2023)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
por: Ward, Alex, et al.
Publicado: (2013)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Deprescribing: Fashion Accessory or Fig Leaf?
por: Zermansky, Arnold G.
Publicado: (2019)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing
por: Alshamrani, Majed, et al.
Publicado: (2018)

Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment
por: Raghunandan, Rakhee, et al.
Publicado: (2023)

Disparities in Anticoagulation Use by Race and Ethnicity in Long‐Term Care Residents With Atrial Fibrillation
por: Kapoor, Alok, et al.
Publicado: (2021)

Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial
por: Cateau, Damien, et al.
Publicado: (2021)

“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
por: Springer, Sydney P., et al.
Publicado: (2022)

Peer-Led Education Expedites Deprescribing Proton Pump Inhibitors for Appropriate Veterans
por: Bowman, Mary H.
Publicado: (2020)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Understanding Global Deprescribing Policy: Opportunities and Challenges
por: Kim, Catherine, et al.
Publicado: (2021)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Deprescribing or represcribing: not just a semantic dilemma
por: Wehling, Martin, et al.
Publicado: (2021)

Polypharmacy and deprescribing: challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Deprescribing practices in Canada: A scoping review
por: Desai, Mansi, et al.
Publicado: (2022)

Clinical aspects of deprescribing process in affective disorders
por: Bouckaert, F.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94kn6q2jhhc05v9hfo408nrl1h